Pharmacokinetics, safety, and 48-week efficacy of oral raltegravir in HIV-1-infected children aged 2 through 18 years.
暂无分享,去创建一个
S. Spector | H. Teppler | E. Acosta | E. Handelsman | S. Nachman | L. Frenkel | B. Graham | C. Worrell | T. Fenton | N. Zheng | A. Wiznia | L. Wenning | Xia Xu | B. Homony | C. Alvero